- Home
- / Okogen
Okogen
Total Funding
$10 M
Okogen Summary
Company Summary
- Overview
- Okogen is a company developing ophthalmic anti-infective drugs. Its product OKG-0301 is designed to treat viral conjunctivitis. The company aims to provide medications for eye diseases.
- Type
- Private
- Status
- Active
- Founded
- 2015
- HQ
- Encinitas, CA, US | view all locations
- Website
- http://www.okogen.com
- Cybersecurity rating
Table of Contents
LocationsView all
2 locations detected
Encinitas, CA HQ
United States
332 Encinitas Blvd #102
Melbourne, VIC
Australia
Level 9/31 Queen St
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026